gms | German Medical Science

17. Jahreskongress für Klinische Pharmakologie

Verbund Klinische Pharmakologie in Deutschland

01. - 02. Oktober 2015, Köln

MetropolMediplan 2016 – MMP16 Evaluation of the acceptance and practicability of the German federal medication list in the metropolitan region Nuremberg-Fürth-Erlangen

Invited Lecture

17. Jahreskongress für Klinische Pharmakologie. Köln, 01.-02.10.2015. Düsseldorf: German Medical Science GMS Publishing House; 2015. Doc15vklipha33

doi: 10.3205/15vklipha33, urn:nbn:de:0183-15vklipha337

Veröffentlicht: 24. September 2015

© 2015 Maas et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe



In October 2014 the Drug Commission of the German Medical Association (AkdÄ) introduced the specifications of a “federal patient oriented medication list” with the aim to better inform patients regarding their medications and to standardize the exchange of medication data between health care providers. In the context of the "Action Plan Medication Therapy Safety (AMTS) 2013-2015" of the German Ministry of Health it is the aim of this ongoing interdisciplinary project to evaluate the implementation and routine use of the medication list by patients and health care providers in metropolitan region Nuremberg-Fürth-Erlangen. The standardized paper printout of the medication list details the complete medication and directions for use in a patient oriented manner. In order to facilitate data exchange between health care providers a 2-dimensional barcode on the medication list provides the same information in a machine readable form. So far, a cooperative network of physicians in private practice, clinics and pharmacies has been set up and standard operating procedures (SOPs) governing the issuing and updating of medication lists by different health care providers have been established. Enrollment of patients for the first of three study phases by physicians and pharmacists has started in June 2015 after study registration, ethics and data protection approval of the study. The interdisciplinary work on SOPs, as well as the technical implementation phase, revealed several practical issues not sufficiently addressed by the current specifications of the medication list. Solutions for these issues have been developed and will be subsequently implemented and evaluated in the remaining project phases. One of these solutions includes the use of the barcode on the medication list to unlock reading and writing access to the patient's mediation list data stored on a central server.

Further information can be found at the URL of the study: and at the German DRKS study registry (ID: DRKS00007844).